Allergan pays top dollar for 'stepping stones' from neurology to dermatology

(Reuters) - Allergan Plc CEO Brent Saunders calls them "stepping stones" - small, bolt-on acquisitions, as opposed to the mega-deals common in the drug industry. And they're expected to boost dealmaking in sectors ranging from neurology to skin care.

Allergan pays top dollar for 'stepping stones' from neurology to dermatology
Read More


Bagikan Berita Ini